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The cornea is the transparent, dome shaped tissue covering the front of the eye. It is a 
powerful refracting surface and provides 65 to 75 % of the focusing power of the eye. 
Corneal injury can result in loss of this transparency, while the rest of the eyeball is 
structurally and functionally intact. This causes decreased vision, a condition termed 
“Corneal Blindness”(1).  
Corneal injury and corneal ulceration result in about 2 million new cases of corneal 
blindness annually(1).
  
Infectious keratitis, or corneal ulcer, is characterized by a 
corneal epithelial defect with underlying stromal inflammation and destruction caused 
by multiplying organisms and their toxins.  Associated uveal tissue and anterior 
chamber inflammation also occur, with an outpouring of leucocytes into the anterior 
chamber, which can then form a hypopyon. (2–4) 
Microbial keratitis is a leading cause of ocular morbidity and blindness worldwide.(1)
 
Delayed or inappropriate treatment of infectious keratitis can lead to significant visual 
loss in as many as 50% of cases (1,5). A large number of fungi, bacteria, protozoa, 
and viruses have been identified and implicated as infectious agents in microbial  
keratitis(5) 
All microbial keratitis requires aggressive management to stop the disease process and 
reduce the extent of scarring which lead to loss of vision(1,6,7) 
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Treatment of corneal ulcers includes the specific antimicrobial treatment as well as 
adjunctive treatment to reduce pain and inflammation, including  cycloplegic agents to 
reduce ciliary body spasm, and anti inflammatory pain killers.(8,9) 
 
In addition to the above, treatment guidelines have generally mentioned antiglaucoma 
medication (Tab. Acetazolamide) as part of this adjunctive treatment.  The rational is 
that  the  intraocular pressure (IOP) would be expected to increase in the presence of 
inflammation and  inflammatory cells within the anterior chamber . This rise in 
intraocular pressure may cause increase in pain, as well as prolong the time to healing 
of the ulcer, leading to poorer outcomes. (10–12) 
Currently, the side effects of Acetazolamide(13) have become more clear, and the 
American Academy of Ophthalmology advises anti glaucoma medication  only in 
those patients where IOP is found to be raised. (14) 
 
The applanation tonometer, which is the gold standard instrument used to check IOP 
in normal patients, (15)cannot be used in this  situation because of the absence of a 
smooth corneal surface in patients with corneal ulcer(15). The easiest method in this 
situation to check for raised IOP, is  digital palpation over the eyelid(16).  This 
method is however highly inaccurate in this situation due to the presence of the  often 
severe lid edema associated with corneal ulcers, leading to frequent under-estimation 
of the IOP(17).Additionally, this method proves to be painful in the patent who is 
already in severe pain due to the ulcer. 
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There are now newer instruments available, e.g. the Tonopen, the I-Care system, etc 
which can be used to get an objective assessment of the IOP for such patients 
(28) (18)
 
However, these instruments are not readily available, are expensive, and incur a 
recurring expense due to the need for caps or disposable tips (to prevent cross-
infection). (18)
 
Thus in a developing country such as ours, where the population that is most affected 
by this health problem is the lower socio-economic sections of society, (19–21) these 
instruments cannot be used for every patient indiscriminately. 
Recently, there have been reports in the literature, that there may be a specific group 
of patients with corneal ulcers who may be expected to experience a raise in 
IOP.(4)We plan to study prospectively, the intra-ocular pressure profile in our 
population of patients with corneal ulcer, to determine if there is indeed a specific 
group of patients, in whom regular objective intraocular pressure  monitoring is 
indicated. We hope to be able to propose patient and ulcer specific treatment 
management protocols, so that  indiscriminate, and unwarranted anti-glaucoma 
medication may be avoided. 
Thus we feel that this prospective study is highly warranted in our country, where the 
corneal ulcer load is much higher than in the West (22) and where the extra expenses 
involved in checking intraocular patients in all patients may not be a viable option 
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AIM 
Study of the intraocular pressure trends in patients with infective corneal ulcers 
presenting to a tertiary center in South India 
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OBJECTIVES 
Primary Objective:  
To compare the Intraocular Pressure prospectively in the affected eye of patients with 
infective corneal ulcers with the opposite unaffected eye of the same patient. 
Secondary Objectives:  
1 )  To determine if rise in IOP leads to prolongation of Time to Heal.  
2) To determine the IOP trend with respect to microbiological profile of patients with 
corneal ulcers.  
 3) To determine if initial presenting size of the ulcer has any influence on IOP.  
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A corneal ulcer is defined as an epithelial defect, with a stromal infiltrate with or 
without a hypopyon (5,22) . Infectious corneal ulcer or microbial keratitis is caused 
due to the multiplication  of microorganisms which includes bacteria,fungi, parasites 
and virus along with inflammation of the corneal tissue. (5)It is sight threatening if not 
appropriately treated.  
In developing countries  like our own, bacterial and fungal corneal ulcers are more 
 common than in the West.(5) (22) 
A study done in Aravind Eye Hospital in South India showed  63% of ulcer   were due 
to fungal  aetiology, while 35.7% were due to bacterial eitiology(23). Fusarium was 
the most common fungus isolated (42.3%) and  Streptococcus pneumoniae was the 
most common bacteria followed by Pseudomonas  aeruginosa and Nocardia. 
The ocular surface has got mechanisms of its own for defence which includes the 
following:(5)  
1) Intact corneal epithelium 
 2) Eye lid closure : reflexive or even just normal blinking  
3) Tear film components like Immunoglobulin A, Lysozymes,  Lactoferrin,  
Betalysins, orosomucoid , ceruloplasmin, complements (5,24)(both classic and 
alternative pathway), corneal epithelial cells which can phagocytose, subepithelial 
mucosal associated lymphoid  tissue (MALT), and normal conjunctival flora with both 
sessile and planktonic bacteria that help  prevent the growth of pathogenic 
microorganisms.  
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The commonest normal flora of ocular surface seen in descending order of prevalence 
are  Staphylococcus epidermidis, Staphylococcus aureous, Micrococcus species, 
Corynebacterium spp, Propionibacterium species, Sreptococcus spp,  and 
Haemophilus influenza.(1-5)  
Dry eye due to autoimmune disorders as well as mucin and lipid deficiency of in tear 
film are predisposing factors for the development of corneal ulcers. Most commonly 
found fungi in healthy   eyes  include  Aspergillus , Candida spp, Penicillium, and  
Cladosporium  species. (1,3) They need organic compounds for growth. 
Risk factors  of fungal ulcers include corneal surgeries,steroid use,chronic keratitis 
,topical anaestheitic use,topical moxifloxacin use,immunosuppression.Usually fungal 
ulcers have an indolent course, with starting symptoms of foreign body sensation with 
slow onset of pain,blurred vision. 
Signs of fungal keratitis are the follows: 
Non specific 
Suppuration,Conjunctival injection 
Epithelial defect, stromal infiltraton 
Anterior chamber reaction 
Non specific 
Infiltrates have feathery margins 
Gray brown pigmentation suggestive of demetiaceous fungi) 
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Elevated edges ,raised slough 
Rough texture 
Satellite lesions 
Intact epithelium with deep stromal infiltrate seen. 
Bacterial ulcers-Types 
1)Staphylococcal ulcers 
Most common gram positive  bacteria,  seen as part of normal ocular flora. It grows as 
pearly white colonies in routine culture. Keratitis occurs in compromised cornea like 
bullous keratopathy, keratoconjunctiitis sicca , ocular rosacea. They show rapidly 
progressive infiltration with the presence of endothelial plaque or hypopyon. The ulcer 
is round or oval with  dense infiltration and a distinct  border. Stromal microabscess is 
also noticed in some cases  
Coagulase negative staphylococcus ulcers are mainly opportunistic infection with 
slow progression 
2) Streptococcal ulcers 
Mostly occur after trauma, dacryocystitis, filtering bleb infections. Ulcers  are   
purulent  and rapidly  progressive .There is severe anterior chamber reaction  with  
retrocorneal fibrin coagulation.  Perforation is common 
3) Pseudomonas ulcers 
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 Pseudomonas the most common gram negative  pathogen  isolated. Commonly seen 
in soft contact lens users.Corneal ring infiltrate can be seen. 
4)Neisseria ulcers 
Obligate intracellular gram negative cocci .Infiltrate  associated with hyperpurulent 
conjunctivitis   and chemosis 
5) Bacillus ulcer 
Bacillus cereus is a gram positive bacillus which can cause devastating keratitis. 
Intraocular extension is caused by  exotoxin 
6)Nocardia ulcers 
The infiltrates  has a ring like appearance, pinhead like infiltrates with a wreath 
pattern. There can be associated satellite lesions. 
PATHOGENESIS OF CORNEAL ULCER (5,25,26) 
1)Bacterial adherence: In most cases damage to the corneal epithelium is a prerequist 
for bacterial adherence. Bacterial pili or fimbriae enable attachment of the bacteria to 
the glycocalyx of the injured corneal  tissue.  
2) Bacterial invasion : Starts within hours and may peak in 2 days.  Polysaccharides in 
the capsule can stop the activation of the alternate complement pathway. 
Lipopolysaccharides can activate inflammatory mediators and some bacterial 
exotoxins can result in corneal cell necrosis. Proteolytic enzymes that are produced by 
the bacteria lead to destruction of  corneal stroma and collagen fibrils. 
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Some bacteria like Neisseria meningitides, Neisseria gonorrhoea, C.diphtheria , 
Haemphilus aegypticus , Shigella and Listeria monocytogenes  care able to penetrate 
intact corneal epithelium. (5,27) 
3) Corneal inflammation:This occurs through the kinin forming , clotting and 
fibrinolytic system.  Immunoglobulins as well as complement componenets, 
vasoactive amines, neuropeptides and cytokines (EGF,TGF beta S,Hepatocyte growth 
factor in tears) also contribute to this. 
 
NATURAL COURSE  OF CORNEAL ULCERS (1,4,6) 
Patients can present with pain, photophobia, decreased vision, conjunctival congestion 
and anterior chamber reaction with or without hypopyon.  
Clinical signs of active corneal  ulcers are as follows:  
1) Epithelial defect  
2) Suppurative corneal stromal infiltrate  with distinct  edges, edema and white cell 
infiltration in surrounding stroma 
3)Anterior   chamber  reaction with or without hypopyon. 
Severe lesions, with an infiltration diameter of  more than  6mm and those involving 
deeper  than one third of corneal  thickness can have rapid progression  to perforation 
and  sclera  involvement 
24 
 
In the last few years, there has been comparatively little published on corneal ulcers 
since practically nothing new has developed on this subject. Evans(28) states that out 
of 700 elderly blind people, 45 were blind because of corneal opacities.  Most of the 
corneal opacities were caused by corneal ulcers. Considering the huge number of 
corneal opacities that are caused by corneal ulcers which produce partial  or total 
blindness, the necessity for further study in the management of this disease becomes 
clear.  
The behavior of the human cornea in health, disease as well as injury has been quite 
well established by several investigators, and although there are still a few conditions 
that  are not completely undertood, there has been progress leading to a satisfactory 
understanding of the healthy as well as the diseased cornea. (1,3,6,7) 
 
Clinical signs of healing of ulcers (5) 
1. Reduction of  edema and inflammatory cells in the cornea 
2. Reduction in the anterior chamber  inflamation 
3. Re-epithelialization 
4. Halting of  thinning of cornea. 
5. Blunting of the edges of corneal infiltrate and decrease in the density of the 
infiltrate 
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As part of investigation almost aii patients will undergo scraping. Done for initial 
debridement of microbes and sloughed epithelium. Scraping is done from the  leading 
edges and not from base of ulcer.But Moraxella can be well detected when scraping  is 
done from the base of ulcer. Scraping material is inoculated  into  the   solid  media  
(Blood  agar, Chocolate agar, and Sabourad’s dextrose agar) as well as  smeared to the 
microscopic   slide 
 
STANDARD TREATMENT PROTOCOL IN CORNEAL ULCERS 
Corneal ulcers are one of the few true Ophthalmological emergencies. (5) 
The treatment of corneal ulcers cannot be delayed, as this will worsen the already poor 
visual prognosis further. 
There are different approaches   in the initiation of treatment in corneal ulcers 
 
Empirical approach (5,11,29) 
In places where investigations are not possible, immediate broad spectrum  topical  
antibiotics can be started  without corneal scraping. It is always convenient  and cost 
effective. However, in situations where the organism is an unusual one, or is resistant 
to conventional antibiotics, valuable time will be lost, and a poor result obtained. 
Microbiological Culture - guided approach:(30)  
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Even though this is more costly, it is the more scientific approach, providing a definite 
eitiologic diagnosis. Antibiotic sensitivity profiles can be studied, so that effective 
medication can be administerd so that progression of the ulcer is halted and healing of 
the ulcer occurs as rapidly as possible.  
inflammation.This is strictly contraindicated in fungal ulcers. 
 TREATMENT OPTIONS IN COMPLICATED CORNEAL ULCERS 
1)Cyanoacrylate tissue adhesivesTo treat corneal thinning,descematocele,and 
corneal  perforation. 
2)Therapeutic soft contact lensesTo facilitate epithelial healing 
3)Conjunctival flap For recalcitrant microbial keratitis 
4)Penetrating Keratoplasty In old age,delay in referral,excessive steroid use, 
previous  surgery  in eye, large size of ulcer  and centrally locating ulcers. 
INTRAOCULAR PRESSURE IN CORNEAL ULCERS 
Our literature search revealed only one study which  looked at intraocular pressure  
measurements in patients with active cornea ulcers . (4)This  report, from Jules  Stein 
eye institiute,California , was a retrospective study where 184 patients with culture 
positive microbial keratitis were  studied. Those patients with intraocular pressure 
(IOP) more than 22 mmHg or higher  in the affected eye were taken as the cases (52 
of 184 patients – 28%) and those with intraocular pressure less than 22 mmHg in the 
affected eye were the controls. They found that the mean intraocular pressure in the 
High IOP group was 29.1 mmHg (range: 22 – 51).  
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They also found that the “time to healing” (ulcer resolution) was longer in the high 
IOP group (mean 50.1 + / - 53.2 days) than in the control group(mean, 31.6 + / - 42.0 
days; P=0.005).  
Final visual acuity of 20/40 or better was achieved by more patients in the control 
group (47%) than in the high IOP group (20%;P<0.001). 
They therefore concluded that elevated IOP is present in a significant proportion of 
patients with active keratitis and that raised IOP was associated with poorer out 
comes. Hence a recommendation that routine IOP measurement is essential in all 
cases of corneal ulcers to avoid possible optic nerve damage secondary to high 
pressure was made. 
In 1997-1998, a preliminary prospective study was conducted in our department          
(unpublished data) on corneal ulcer patients and it was found that there  were probably 
at least two subgroups of patients who tended to have raised IOP i.e; in patients with 
pneumococcal ulcers and patients with fungal ulcers with hypopyon. 
TONOPEN 
The Tonopen is an instrument that has been documented to be useful in recording 
intraocular pressure in eyes  having scars or ulceration  of the cornea. (15) The 
Tonopen is an easy to  use, handheld   instrument that  uses  micro  strain  gage  
technology and a  1 mm  transducer tip.(31,32).The tip is covered with a new thin 
sterile disposable latex cap before each use.  
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After checking the caliberation, topical anaesthetic agent (paracaine 1% eye drops)  is 
instilled into the eye.  The tip of the instrument is then touched momentarily ( feather 
light touch) to the cornea lightly and then withdrawn .The tip must be kept 
perpendicular to the centre of  cornea.  Over-intendation of the cornea can cause 
falsely high IOP readings. The measurement is digitally displayed each time a valid 
reading is obtained. After 4 readings the final bleep will sound and the average 
measurement will appear on the LCD along with the single bar denoting statistical 
reliability (coefficient of variation) . A reliable reading will show a coefficient of 
variation 5%. Three reliable readings are taken and the average of these values of IOP 
at that point of time is obtained. Other causes of error and unreliable readings that 
should be avoided incorrect  tip cover tension , wrong caliberation, dirt over the 
transducer tip.  Some people  can have allergy to latex which causes local and 
systemic  reaction which can affect the readings.(33) 
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Tonopen used for intraocular pressure mesurement 
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Measurement of intraocular pressure in one of our study subjects 
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IOP MEASUREMENT IN CORNEAL  ULCERS 
Objective measurement of IOP is not performed routinely in patients with infective 
corneal ulcers, as special instruments like the Tonopen is required . But growing 
evidence suggests that there is a subgroup of corneal ulcer patients who experience a 
rise in IOP which may result in poorer outcome 
2
. 
The cause of IOP elevation in acute ucerative keratitis  in a subset of people is not 
actually understood clearly. This may be due to multiple factors . 
Non-infectious uveitis usually presents with decreased or normal IOP 
3,4
.  In infectious 
uveitis e.g. viral uveitis, an increase in IOP is noted. (4)Microbial keratitis may have a 
similar pathophysiology.  
The anterior chamber reaction  causes  “blood-aqueous barrier”  breakdown with the 
release of inflammatory  polymorphonuclear cells  and proteins. These can block the  
trabecular meshwork. (4)Prostaglandins released during inflammation in the eye may 
also play a role in the increase of  IOP.(4)  Microbial  toxins have also been described 
to cause an increase in IOP.(3,4)  None of the studies retrieved from our literature 
search so far has suggested evidence of  a specific organism or microbial toxin which 
by itself may cause an increase in IOP.   
IOP elevation in corneal ulcers may be caused by both angle closure  and open angle 
mechanisms.  
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Angle closure is caused by  inflammation and  anterior or posterior synechiae 
formation. A specific type of pupillary block glaucoma, called “Malignant Glaucoma” 
has been described in Fungal ulcers.(34) It is caused by a mushroom – shaped growth 
of fungal elements from the anterior chamber, through the pupil, into the posterior 
chamber. This causes pupillary block, which has to be adressed surgically. 
Open angle mechanisms of glaucoma, as described previously, are possibly due to 
increased inflammatory cells, exudation of high-molecular wieght protiens, as well are 
micro-organism toxin liberation into the anterior chamber (9)  
INCLUSION CRITERIA 
1) All suspected suppurative corneal ulcers more than 2mm size who have 
undergone microbiological scraping for smear and culture (including fungal 
and bacterial) 
2) All patients 18yrs or above who are able to give consent  
EXCLUSION CRITERIA 
1. Perforated corneal ulcers 
2. Ulcers clinically diagnosed as immune – related peripheral keratitis 
3. Patients on anti-glaucoma medication within 48 hours of presentation to this 
department 
4. Patients with bilateral ulcers 
5. Patients presenting with descemetocoel 
6. One – Eyed patients 
Withdrawal of the patients from study after recruitment:   
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Patients initially recruited and undergoing standard medical therapy will be withdrawn from 
the study if:  
1. They undergo any surgical intervention e.g. intracameral injections, therapeutic 
keratoplasty during the course of their treatment in this hospital. 
2. Intraocular pressures are found to be raised  to 50mmHg for more than 72 hrs.  
Guidelines for treatment of acute / temporary elevations of IOP are not available for infective 
keratitis.  We therefore decided to use the guidelines published for the management of blunt  
trauma patients with hyphema  (Blood in the anterior chamber).An intraocular pressure of 
50mmHg for more than 4 days requires intervention to bring down the IOP in order to 
prevent pressure-related optic nerve damage.
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However, patients with raised IOP will be closely followed for development of any evidence 
of posterior segment vascular or optic nerve compromise, and if any risk is perceived, earlier 
intervention will be performed.  
Those patients who require interventions will be started on anti-glaucoma medication as 
indicated (Oral/topical/intravenous). These patients will be taken out of the “Time to Healing 
“ analysis.  All such patients will  be analyzed separately. The IOP trend and differences as 
compared to the normal (unaffected) eye will be recorded and analyzed.  
All  known  glaucoma patients with normal IOP on regular treatment will be included in the 
study. These patients can be continued with their antiglaucoma medication.  
 
OUTCOMES USED FOR STUDY 
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1. IOP variation: Trend of IOP variation in suppurative corneal ulcers ulcer eye 
(study eye) compared to unaffected normal eye (control eye) of the patient. 
 
2. Time to Healing: Time from start of symptoms, to healing.  
The “Time to Healing” in patients with raised IOP will be determined and compared with the 
“Time to Healing” of those patients who do not get a raised pressure. 
3. Clinical Outcome: A poor clinical outcome has occurred if a complication such as 
corneal perforation, emergency corneal transplant or evisceration has ensued. 
Healing of  corneal ulcer: End point – Complete closure of the epithelial defect with  
complete resolution of infiltrate 
Non - healing of corneal ulcer:  
 Complication of ulcers with descematocele,perforation, evisceration or 
atrophy/phthisis of eyeball 
 Ulcers for which therapeutic keratoplasty was done 
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Study design: 
Case control design :  IOP in case or ulcer eye compared to IOP in control of 
unaffected eye 
Secondary objectives : 
Observational  study  for correlation with microbiological profile and ulcer size at 
presentation.  
 
SAMPLE SIZE CALCULATION 
This was purely an observational study done in our hospital and all those patients who 
presented to us who satisfied  the inclusion and exclusion criteria during the duration 
of the study were   recruited.  
In  this study, out of the 92 patients who presented to our department from January 1
st
 
2015, to July 31
st
 2015 with corneal ulcers, 46 patients who satisfied the study criteria 
were  recruited.    Of these patients, 19 patients were withdrawn due to  need for 
surgical intervention as outlined above. No patient was removed due to prologed 
elevated intraocular pressure. 
In all,  27 patients were included in the study.  
This study protocol was approved by the institutional review board and ethics 
Committee of Christian Medical College, Vellore  as per the ICMR guidelines 
required for any study conducted in this institution. A written informed consent was 
obtained from  everyone who underwent this study. 
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Methodology: WORK-FLOW CHART 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Informed consent of recruited patients 
History taking  & Slit Lamp ocular 
examination   
IOP measurement with TONOPEN for ulcer eye(case) and normal 
eye(control) on the day of admission(D-0),and every third day (Day 3,Day 
6,Day 9,Day 12....)  till healing. 
- Normal eye checked first to prevent cross infection. 
- Average of three readings each time for  each eye  
Recruited 27 patients with active corneal ulcers from 1st January 
2015 to 31st July 2015 
Scraping of ulcerObtaining 
microbiological result 
Analysis  
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Materials & Methods 
Patients who presented  to the out-patient  and casualty departments  of our hospital 
with active corneal  ulcer  during  the  study   period   were assessed  for eligibility  for  
this  study.  
27 patients were finally included in this study.  
Detailed history including hospital number , name, age, sex, address, contact number, 
date and time of presentation,  symptoms with which they present are taken. History 
of  medications prior to presentation and  systemic illness also taken. Visual acuity at 
presentation was noted down in both eyes. 
After this all patients underwent slit lamp examination during which the following 
parameters were assessed: 
 
 Site  and  size  of  infiltrate 
 
 Size  of  epithelial  defect 
 
 Location (involving visual axis or not) 
 
 Depth of involvement 
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 Thinning in percentage 
 
 Corneal sensation 
 
 Endothelial plaque 
 
 Previous scars 
 
 Vascularisation  
 
 Presence or  abscence of hypopyon 
 
 Satellite lesions 
 
After examination all patients underwent   corneal scraping under aseptic conditions 
for microbiological testing.  For those patients who  were already  on some other  
antibiotic  drops from elsewhere  a waiting period of 6 hours    from the time  last 
instillation was given, and then scraping done . 
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Gram  staining  for  bacteria  and   Lacto-Phenol  Cotton  Blue  smears for  fungus  
were  done.  In  addition,  Calcofluor White  Fluorescent  microscopy  was  performed  
in  cases  where both the above  smears  are  negative.  
For  culture  , specimens  were inoculated  into  blood  agar, chocolate  agar  and 
Sabouraud  dextrose  agar (SDA) media   and they were incubated  in  the  
microbiology  department  for  a  total  of   10 days  to  2  weeks,  depending  on the  
media .  
Smear-based medical therapy was started in all patients, which was modified as 
required once the sensitivity reports were available. 
 
Treatment of all the corneal ulcers was according to our standard therapy protocols as 
follows. 
Gram negative bacteria in smear/ smear negative for bacteria or fungus: 
-Fortified Gentamycin eye drops (1.45%) + Cefazoline drops(50mg/ml) 
Gram positive bacteria in smear: 
Crystalline Penicilline 1 lac units/ml + Fortified Gentamycin drops 
Fungal hyphae in smear: Natamycin  eye  drops 5%  
+/- Tablet Ketoconazole  200 mg  twice  daily  ( based on depth of ulcer ). 
All drops  were  started  at  hourly  intervals.  
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For other  suspected organisms  e.g.  Acanthamoeba  / Nocardia , specific culture 
media and therapy  as per  department  protocols were followed. 
Additional supportive therapy:  
Atropine  sulphate  eye  drops  1%  to reduce pain because of ciliary muscle  spasm. 
-Antiinflammatory  pain  killers 
or perforation  - glue  and  contact  lens  
  
 
METHOD OF INTRAOCULAR PRESSURE RECORDING IN ULCERS 
 
On the day of admission the intraocular pressure was noted in both eyes using the Tonopen as 
follows.  
An  anaesthetic drop ( Paracaine 1% ) was instilled in both eyes. A thin sterile disposable 
latex cap was used on the tip of the Tonopen before each use. Recordings of IOP were taken, 
first from the normal eye and then from the study (ulcer) eye. An average of three recordings, 
each with a coefficient of variation of of 5% were taken. The IOP in the normal (control) eye 
was recorded first to prevent cross-infection.  
Intraocular pressures at an interval of 3 days were then taken in both eyes. Further recordings 
were taken as per the duration of admission at 3 day intervals.  All efforts were made to take 
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IOP between 4pm and 8pm for each patient, to minimize the effect of diurnal variation of 
IOP. 
Figure showing measurement of Intraocular pressure with Tonopen in our institution 
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As per our department protocol, when the ulcer showed good improvement with treatment, 
the patient was discharged and followed up in the “Septic OPD”, till complete healing 
occurred.  
The signs of healing and the response to therapy noted at each visit were:  
1. Decrease in corneal edema and inflammation of endothelium 
2. Reduction in anterior chamber inflammation 
3. Re - epithelialisation 
4. Cessation of thinning of cornea 
5. Decrease in infiltrate size and density 
 
The time taken for the ulcer to heal was noted. 
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                                                       RESULTS 
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This was case control study which was carried out the Department of Ophthalmology, 
Christian Medical College Vellore 1
st
 January 2015 to 31
st
 July 2015. A total of 47 
patients were recruited, of which 20 patients were excluded for the above said reasons; 
27 patients remained for final analysis 
 
1. DEMOGRAPHIC PROFILE OF ALL PATIENTS RECRUITED 
The average age of the study population was  20 to 80 years(Min to Max). When sub-
classified, majority of the patients belonged to the mid age, aged between 31 to 60 
years(17 patients). Most of the patients belonged to the Southern states of India with 
majority coming from Tamil Nadu. Among the 27 patients only 1 patient had systemic 
risk factor of Diabetes Mellitus who was on treatment from elsewhere, at the time of 
presentation. Nearly 50 % (14 patients) had some sort of topical treatment at the time 
of presentation to our hospital.  
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Pie chart 1 :  Gender distribution of cases 
 
 
 
There was almost equal representation of males and females in our cohort of patients. 
 
 
 
 
55.55%-males 
    44.44%-females 
 
0% 
 
0% 
Demographical profile 
n=27 
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Pie chart 2: Age group affected: 
 
 
The maximum number of patients fell in the 31 – 60 year age group. This is 
representative of the population who are in the working age group who would be 
susceptible to trauma to the eye. 
18-30yrs 
19% 
31-60yrs 
66% 
>60yrs 
15% 
Age group 
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2. PATIENT CHARACTERISTICS 
Pie chart 3: Systemic illness 
 
 
 
Only one patient each were found to be diabetic and hypertensive in the cohort of 27 
study patients. 
 
4% 4% 
92% 
Systemic association 
Diabetes Hypertension No systemic illness 
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Pie chart 4: Prior Treatment from Elsewhere 
 
 
 
Almost equal numbers of patients had sought treatment from centres other than our 
own before presentation, as compared to those who presented in our department 
primarily. 
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52% 
no 
48% 
Prior  treatment 
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3. ULCER CHARACTERISTICS 
 
In our study population (n = 27), the majority were proven fungal ulcers (10 patients) 
followed by 7 patients with bacterial growth, Nocardia (2 Patients) and Acanthamoeba 
(1 Patient). A significant number of patients (7 / 27 or 25.9 % ) did not have any 
growth identified in the routine culture.  
 
Graph 1: Microbiological Profile of the organisms grown (n=27) 
 
 
 
 
0 
1 
2 
3 
4 
5 
6 
7 
8 
Microbiological profile  
51 
 
 Table 1:  Microbiological Profile numbers 
Fungal Ulcer 10 
Bacterial Ulcer 7 
Nocardia 2 
Acanthamoeba 1 
No Growth 7 
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Pie Chart 5 : The microbiological profile 
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Pie chart 6: Species distribution of fungi grown 
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Pie chart 7:  Species distribution of bacteria grown  
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Pie Chart 8: Size distribution of the Ulcers studied 
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Pie chart 9: Hypopyon  at presentation 
 
 
 
9 among 27 (33%) patients presented with hypopyon.  
The following table depicts the distribution of the ulcers that presented with 
hypopyon. 
Table 2: Table depicting the distribution of hypopyon among the ulcers 
TYPE OF 
ULCER 
BACTERIAL FUNGAL NO 
GROWTH 
NOCARDIA ACANTHAMOEBA 
NUMBER 2 4 2 1 0 
 
yes 
33% 
no 
67% 
Hypopyon 
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Pie chart 10: Endothelial plaque at presentation 
 
 
Only 7% (2/27) of all the ulcers had an endothelial Plaque at presentation.  
The endothelial plaque was present in one patient with a bacterial ulcer, and in one 
patient where there was no growth of any organism. 
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4. ANALYSIS OF INTRAOCULAR PRESSURE TREND IN ULCER EYE  
Graph 2: Intra ocular Pressure trend in Ulcer Eyes and Normal Eyes 
 
 
 
 
 
 
This graph depicts the trend of the  intraocular pressure of the Ulcer Eye and the 
normal opposite eye . It can be seen that in the early part of the ulcer course, the 
intraocular pressure is higher than the opposite eye.  However, beyond the 15
th
 day, 
this trend reverses, with the normal eye showing higher pressure.  
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Graph 3: Intraocular pressure Trend in Ulcer Eye versus size of ulcer 
 
 
This graph reveals that there is no specific effect of size of the infiltrate on the 
intraocular pressure. On day 3, the smaller ulcers seem to have a dip in the intraocular 
pressure. 
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Graph 4: Intraocular pressure Trend in Ulcer Eye versus Etiology of ulcer 
 
 
 
 
 
 
This graph demonstrates that the bacterial ulcers show a trend for a higher intraocular 
pressure as compared to the other ulcers 
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Graph 5: Graph depicting the average IOP difference between the ulcer eye and 
the normal eye in Bacterial, Fungal, and Others ulcers (includes no growth- 7, 
Nocardia -2, and Acanthamoeba-1) 
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This graph shows that in general, the ulcer eye had a higher average IOP in the 
“Bacterial” and “Others” groups, with the “Fungal” ulcers being almost equal to the 
opposite unaffected eye. However, interestingly, the bacterial ulcers had a statistically 
significant higher IOP (P value:0.01) compared to the other groups.  
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Graph 6: Graph depicting the average IOP difference between the ulcer eye and 
the normal eye in the 7 bacterial isolates 
 
 
This graph(graph 6) shows the tallest spike in a patient with Streptococcus pneumonia. 
Out of the 7 bacterial ulcers showed a higher IOP in the ulcer eye compared to the 
normal eye. 
In contrast, the following plot shows on the same scale, that the average IOP 
difference between the ulcer eye and the normal  eye in the 10 patients with fungal 
isolates (Graph 7), was much smaller. 6 out of the 10 patients had lesser IOP in the 
ulcer eye as compared to the normal eye. 
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Graph 7: 
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6. ANALYSIS OF “TIME TO HEALING” IN ULCER EYE  
The average Time To Healing of the 27 ulcers included in this study was 24 
days.The subanalysis based on IOP,size of ulcer and microbiological isolate 
given below. 
1. MEAN TIME TO HEALING OF ULCER EYE WITH RESPECT TO 
INTROCULAR PRESSURE 
For this part of the analysis, a mean INCREASED intraocular pressure of 4mmHg 
(Mean IOP difference > +4mmHg) or more in the ulcer eye as compared to the control 
eye was considered  as the exposure, called the “High IOP Eyes. The ulcer eyes in 
which the mean IOP of  the ulcer eye was less than 4mmHg higher than, equal to or 
less than the control eye (Mean IOP difference < 0mmHg / = 0mmHg / 
<+4mmHg)were considered “Normal IOP Eyes” 
Table 3: Mean Time to Healing of Ulcer eye with respect to Introcular pressure  
 
 Mean Time to Heal 
(Days) 
Standard Deviation 
Normal IOP Eyes  
(n = 21)  
20.62 7.35 
High IOP Eyes 
(n = 6) 
23.67 8.04 
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The “Time to Healing” was marginally higher in the “High IOP Eyes” group with a 
“p” value of 0.58.  This difference was not statistical significant. 
The following is a bar graph depicting this. 
Graph 8: Difference in Mean Time to Healing of Ulcer eyes with “Normal IOP” 
and “High IOP” 
 
 
 
 
 
Normal IOP Eyes High IOP Eyes 
67 
 
 
 
 
3. MEAN TIME TO HEALING OF ULCER EYE WITH RESPECT TO SIZE OF 
THE ULCER. 
 
For this analysis, the ulcers were grouped into 3 groups as follows: 
 <2mm size,  2 – 4 mm size and   > 4mm size. The following table displays the results.  
 
Table 4: Time to Healing with respect to size of ulcer. 
 
 Time to Healing  
(Days) 
Standard Deviation 
Ulcer size <2mm 
(n = 4) 
16.75 7.27 
Ulcer size 2 – 4 mm 
(n = 15) 
20.47 8.17 
Ulcer size > 4mm 
(n = 8) 
25.13 4.52 
 
This is depicted in the following graph. 
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Graph 9: Mean Time to Healing in eyes with increasing size of Ulcer  
 
 
The above table and graph demonstrates that the Time to Healing increases as the size 
of the ulcer increases. However the differences did not reach statistical significance (p 
= 0.23).  
 
 
Ulcer Size 
69 
 
 
 
 
4.  MEAN TIME TO HEALING OF ULCER EYE WITH RESPECT TO THE 
MICROBIOLOGICAL PROFILE OF THE ULCER 
 
Table 5: Mean Time to Healing with respect to microbiological profile 
 
 Time to Healing 
(Days) 
Standard Deviation 
Bacterial Ulcers 
(n = 7) 
19.71 6.95 
Fungal Ulcers 
(n = 10) 
23.11 6.57 
No Growth 
(n = 7) 
22.25 9.00 
Nocardia Ulcers 
(n = 2) 
12.50 3.54 
Acanthamoeba Ulcer 
(n = 1) 
26.00 5.24 
 
The following displays the above data in graphical form. 
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Graph 10: Time to Healing with respect to microbiological profile 
 
 
The differences noted above did not reach statistical significance (p = 0.27 
 
 
 
Microbiological Profile of Ulcers 
71 
 
 
 
 
 
 
                                        
 
 
 
DISCUSSION 
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Infectious keratitis  is  caused due to the proliferation  of  microorganisms like 
bacteria,  fungi,  virus and  parasites,  which leads  to the destruction of   corneal 
tissue. The proteases  produced  by bacteria causes destruction of the  stromal  
collagen  and proteoglycans. Additionally, exotoxins  produced  by some  bacteria like 
Streptococci, Staphylococci,  and  Pseudomonas aeruginosa  can  cause corneal  cell  
necrosis.(5)  
Normal conjunctival  flora  can  also  become  opportunistic  pathogens  in 
immunocompromised eye. (35) 
Most of  the  bacterial  corneal  ulcers  develop  at  the  site  of  epithelial defect in 
cornea.  However, there are some organisms  e.g. N. gonorrhoeae, N.meningitidis, 
Corynebacterium diphtheria, Haemophilus aegypticus  and Listeria  monocytogenes, 
Shigella spp;  which can  invade intact epithelium of cornea. 
Central  corneal  ulcers  after healing  cause  significant  visual impairment because of 
the scar that is produced by the healing process.   
Fungal  corneal ulcers usually  show  an  indolent  course. The  patient  may present  
with  foreign  body  sensation in eye  with  slow onset  of  pain  and blurred  vision 
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It is  difficult to distinguish between infectious and non infectious ulcers and they 
need to be treated with anti-inflammatory medications. Most of the presenting cases 
are infective in aetiology. 
 
A patient with a corneal ulcer ideally undergoes a battery of microbiological 
investigations inluding Smears for bacteria (Grams-stain) and Fungus (Potassium 
hydroxide- KOH, or Lactophenol Cotton Blue –LPCB), and culture plating in Blood 
agar, Saboraud Dextrose Agar and Chocolate Agar. If Acanthamoeba is suspected, 
Non-nutrient agar  with E coli overlay is also used. Based on the results of the smear, 
and later the culture and sensitivity profile, appropriate topical medication is started 
and modified as required. Systemic anti-microbial medication is not used except in 
fungal ulcers where there is suspicion of hyphae infiltrating through the corneal 
endothelium into the anterior chamber.  
Even with all these measures, the lack of vascularity of the cornea, the tight junctions 
of the epithelial and endothelial cells, as well as the lipid solubility/aqueus solubility 
issues of the medications used, results in difficulty in healing of the ulcer, usually 
necessitation weeks of in-patient care to get the ulcer under control.  
In our population, any additional factor that prolongs hospital stay is detrimental to the 
patient’s socio economic status. 
Hence any factor which impedes the healing process like dry eyes, trichiasis, etc have 
to be treated sideby side.  
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Healing of the ulcer depends upon many factors.  
1. The presenting  size of the ulcer has a significant role in the time to heal. In this 
study also, the larger size ulcers showed a signific longer time to heal than a smaller 
sized one.The outcome of a corneal ulcer always depends on how early the ulcer is 
diagnosed and treated. Those ulcers which are small , superficial,mostly limited to the 
anterior most cornea, which are treated with appropriate topical antibiotic drops will 
heal faster. But at the same time the ulcer in a compromised  cornea which is large in 
size will take more time to heal.  
2. The organism causing the ulcer may respond rapidly to the medication used. 
However, some organisms may be resistant to the medications that are used, or the 
organism may be one that causes indolent ulcers e.g. Non tuberculous mycobacteria. 
3. The role of raised intraocular pressure (secondary glaucoma) in prolonging the time 
taken for the ulcer to heal is currently. This aspect of corneal ulcers has been very 
sparsely studied. A study(4) published in 2011 has however highlighted this, and it 
was found that the raised IOP is infact associated with an increased time to healing.  
The reasons for this may be: 
a.  Inflammation of the anterior chamber associated with inflammation of the 
trabecular meshwork in the ulcer eye i.e. associated trabeculitis. 
b. Blockage of the trabecular meshwork by infalmmatory debris in the anterior 
chamber 
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c. Pupillary block due to inflammatory membranes across the pupil. Pupillary block 
due to growth of fungal elements across the pupil causing “malignant glaucoma” has 
been documented. (36) 
d. Inflammatory cytokins and molecules released by certain bacteria may cause 
increased inflammatory reactions and trabeculitis. This may be one of the reasons that 
addition of steroids in the treatment of some bacterial ulcers helps with the healing of 
these ulcers.(30,37) 
In a preliminary unpublished study conducted in our department in 1996- 1999, a 
definite trend for raised IOP in corneal ulcers with Streptococci pneumoniae isolated 
was detected. These ulcers heal faster with reduction of IOP when steroids are added 
to the treatment protocol. 
Once the patient starts showing signs of healing like decrease in pain, redness, 
blunting of the perimeter of infiltrate and resurfacing of the epithelial  defect , the 
frequency of the topical antibiotics should be reduced to avoid the potential side 
effects . 
About present study: 
In this study, conducted in Schell eye hospital , CMC, from 1
st
 January 2015 to  31
st
 
July 2015, 46 patients with active  ulcers  were enrolled  initially. Among those  46  
patients 5 patients had  descematocele formation , 6 patients had  perforation, and 8 
underwent ocular interventions. A total of 27 patients were included for the analysis. 
Most of them were from  Vellore district  and mostly from rural areas. Most of them 
were agricultural workers as their main occupation.  
76 
 
The majority of the patients  who presented  were in the age group  31-60 years, which 
represents  the working group in the  society.  
Among the 27 patients there was  one with hypertension and  one with diabetes  
mellitus. None of the rest patients were not known to have any systemic illness .This 
may represent the lack of knowledge about there own health as the people from 
villages were not aware about the importance of routine health checkups.  
Out of 27 patients 14 patients received some sort of  ophthalmic treatment prior to 
presentation to our hospital. 
All patients who underwent  scraping and were admitted here, were started on topical 
medication according to the smear and culture reports as per standard hospital 
protocols detailed above.  
Intraocular Pressure Recording 
Intraocular pressure was checked with Tonopen after caliberation, with he normal eye 
IOP  being checked first so that no transfer of infection occurred. The difference 
between the IOP was also noted between two eyes. The same procedure is repeated at 
three day intervals. Great efforts were taken to make sure IOP was recorded at almost 
the same time (4pm – 8pm) in all patients, to avoid bias due to diurnal variation of 
intraocular pressure. 
In our study, we found that bacterial ulcers had a higher IOP in the ulcer eye as 
compared to the unaffected opposite eye. On an average after 9 days, the IOP of the 
ulcer eye started to become stabilized. In many of the  ulcers, the IOP in the ulcer eye 
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was lower than that of the unaffected eye. This is what is usually seen in patients with 
non infectious anterior uveitis. 
It is extremely interesting to note that in our study, the average IOP difference in the 
bacterial ulcers (higher IOP in the ulcer eye) was larger than the average IOP 
difference in the fungal ulcers, and the other ulcer (no growth / nocardia / 
acamthamoeba) groups. This difference was statistically significant.  
Additionally, on break down of the individual IOP difference for each bacterial isolate 
obtained, the highest IOP diference (higher IOP in the ulcer eye) was found for 
Streptococcus pneumoniae isolate. However, the sample size is too small to make any 
kind of generalization about this finding. 
Analysis of the “time to healing “ was done for  
1. IOP difference between the ulcer eye and the opposite normal eye: the exposure 
being a higher IOP in the ulcer eye: 
Patients who had a difference in IOP between the study eye and the normal eye of (a) 
More than + 4mmHg i.e. IOP in the ulcer eye 4mmHg or more higher than the normal 
opposite eye compared to  
(b) those with difference in IOP less than 4mmHg (higher in the ulcer eye) and those 
with IOP less in the ulcer eye than in the normal eye.  
The results of this analysis was not statistcally significant. Hence our study could not 
show that the time to healing was influenced in any way by the IOP in the ulcer eye. 
This maybe due to the small sample size studied. 
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2. Size of the infiltrate:  
Here, the results of our analysis did not show a statisticaly significant difference in the 
“time to healing” between the 3 sub groups studied. There was however a clear trend 
demonstrating a longer time taken to heal as the ulcer size increased. This seems 
intuitively plausible. 
3. Microbiological Profile:  
Here as well, the results of our analysis did not show a statisticaly significant 
difference in the “time to healing” between the different microbiological isolates 
obtained.  
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SUMMARY 
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Infectious keratitis  is an ocular emergency as it is a  sight threatening condition 
worldwide, which is a major public health issue. The age group mostly affected is the 
middle age group. Most of the patients in our population are from rural areas and 
majority are agriculturalists as occupation.  
All the 27 patients who were included in the study after microbiological scraping were 
started on  standard therapy as per department protocol. Those who were selected for 
this study additionally had intra ocular pressure (IOP) measurements taken at intervals 
of 3 days, between 4pm and 8pm, with the Tonopen. 
Healing time of the ulcer was considered as the time between presentation to us and  
closure of the epithelial defect with resolution of the infiltrate.  
The  main objective of the present study was  to study the trend of intraocular pressure 
variation between the ulcer eye and the normal eye. The secondary objectives were to 
determine if “Time to Healing” was affected by a raised IOP in the ulcer eye, the size 
of the ulcer at presentation, and the microbiological profile of the patients. 
The average “Time to Healing” of all the ulcers included in this study was found to be 
24 days.  
 The  analysis of the results of the IOP monitoring did not show show a clear trend of 
IOP in the ulcer eye of the population studied, except for a suggestion that bacterial 
ulcers may tend to have a higher IOP in the ulcer eye than the unaffected eye, and that 
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perhaps Streptococcus pneumoniae ulcers have an IOP spike that should be monitored 
for and treated appropriately. 
Additionally, this study does not show a significant difference in the “Time to 
Healing” based on raised intraocular pressure in the ulcer eye, size of the ulcer and 
microbiological isolate profile. 
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LIMITATIONS OF THE STUDY 
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1) The  sample size is not adequate to comment about the IOP trends and 
correlation of IOP, size of ulcer and microbiological profile with the healing 
time. 
2) Some of the eligible patients who were recruited initially had to be withdraw 
from the study  due to surgical interventions  
3) A few  patients did not come for follow up for the complete study course. 
4) A large number with “ no growth “in culture limited  the  scope of  large scale 
microbiological analysis 
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CONCLUSION 
 
 
 
 
 
 
 
 
85 
 
 
 
This study does not show a clear trent of IOP in the ulcer eye of the population 
studied, except for a suggestion that bacterial ulcers may tend to have a higher IOP in 
the ulcer eye than the unaffected eye, and that perhaps Streptococcus pneumoniae 
ulcers have an IOP spike that should be monitored for and treated appropriately. 
Additionally, this study does not show a significant difference in the time to healing 
based on raised intraocular pressure in the ulcer eye, size of the ulcer and 
microbiological isolate profile. However, there is a sugestion that increasing ulcer size 
leads to increasing time for healing to occur. 
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                                          APPENDIX – B 
                            PATIENT INFORMATION SHEET AND CONSENT FORM 
 
 
INFORMATION SHEET 
                   
                        Christian Medical College, Vellore 
                                            Department of Ophthalmology 
 
Study to determine the variation of intraocular pressure in active infective 
corneal ulcers : An observational study in a tertiary eye care centre 
Study number:                  Date: 
Name of participant: 
Hospital number: 
You are being requested to participate in a study to determine the variation of intraocular 
pressure in infective corneal ulcers. After a detailed history and examination, the IOP in both 
eyes will be taken with a Tonopen.   
Tonopen is a surface contact instrument that produces a digital recording of the IOP. The tip 
of the instrument is covered with a thin sterile, disposable latex cap before each use.After 
calibration, topical anaesthetic drops are instilled into the eye, and the tip of the instrument is 
touched momentarily to the cornea lightly and briefly, then withdrawn. 
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 A minimum of four recording of IOP will be taken :at the day of  admission, and then at 
intervals of 3 days and at last follow up. Three readings with SD 5% will be taken and 
averaged to get the value of the IOP for that eye at that time. You will be followed up till the 
ulcer heals. We hope to include about 150 patients  from this hospital for this study. 
Can you withdraw from this study after it starts? 
Your participation in this study is voluntary. Not giving consent for participation in 
the study will not affect your treatment in this hospital. 
What are the potential risks to participants in this study?  
Since, it is an observational study, there are no potential risks in participating in this study. 
The history taking and examination will be according to standard protocol for all patients 
coming with active corneal ulcers 
Will your personal details be kept confidential? 
The results of this study will be published in a medical journal but you will not be identified 
by name in any publication or presentation of results. However, your medical notes may be 
reviewed by people associated with the study, without your additional permission, should 
you decide to participate in this study. 
If you have any further questions, please ask Dr.Bindu Thomas (Tel: 04163071201 ,   
9488816051) or email: binzthomas06@gmail.com  
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INFORMED CONSENT 
 
Informed Consent form to participate in a research study  
 
Study Title: 
 
Study Number: ____________ 
 
Subject’s Initials: __________________ Subject’s Name: _________________________________________ 
 
Date of Birth / Age: ___________________________ 
 
(Subject) 
 
(i)I confirm that I have read and understood the information sheet dated ____________ for 
the above study and have had the opportunity to ask questions related to the 
procedure.I confirm that I have been given the option of undergoing intraocular 
pressure checking in my ulcer eye and normal eye using an instrument called Tonopen 
during my admission in this hospital.The procedure of using Tonopen has been 
explained to me in my own language and i have understood that this procedure may or 
may not have any benefit on my corneal ulcer.  [  ] 
  
(ii) I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical care or 
legal rights being affected.   [  ] 
 
(iii)  I understand that the Sponsor of the clinical trial, others working on the 
Sponsor’s behalf, the Ethics Committee and the regulatory authorities will not 
99 
 
need my permission to look at my health records both in respect of the current 
study and any further research that may be conducted in relation to it, even if I 
withdraw from the trial. I agree to this access. However, I understand that my 
identity will not be revealed in any information released to third parties or 
published.I accept to share the data obtained during analysis in the faith that it 
will be used only for scientific purposes.   [  ] 
 
(iv)  I agree not to restrict the use of any data or results that arise from this study 
provided such a use is only for scientific purpose(s).   [  ] 
 
(v)  I agree to take part in the above study. [  ] 
 
Signature (or Thumb impression) of the Subject/Legally Acceptable  
 
Date: _____/_____/______ 
 
 
 
 
 
Signatory’s Name: _________________________________         Signature:  
 
Or 
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Representative: _________________ 
 
Date: _____/_____/______ 
 
Signatory’s Name: _________________________________ 
 
 
Signature of the Investigator: ________________________ 
 
Date: _____/_____/______ 
 
Study Investigater’s Name: _________________________ 
 
 
Signature or thumb impression of the Witness: ___________________________ 
 
Date: _____/_____/_______ 
 
Name & Address of the Witness: ______________________________ 
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                                        APPENDIX C 
                                               CLINICAL RESEARCH FORM 
 
 
 
PROFOMA   
Serial number: 
Schell no                   
CMC no(if present)                              
Name:                                    
Age (yrs)               
Sex: M/F                 
Address  
                
Tel No: 
Date and Time of presentation:             /                                (OPD / Casualty  -Put tick 
mark) 
Date of starting of symptoms:                
Date  and time of admission:                 /       
SYMPTOMS 
 
 
Is he/she a known glaucoma patient 
YES NO 
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ANY MEDICATION /PREVIOUS CONSULTATION FROM OUTSIDE 
Yes(Mention the 
medication) 
No Not sure 
 
 
 
 
SYSTEMIC ILLNESS 
Diabetes Hypertension IHD Asthma 
 
Others 
 
   
 
 
EXAMINATION 
VISUAL ACUITY         Right eye:                              Left eye: 
In the ulcer eye 
 Size of infiltrate                                            
 Size of epithelial defect                                
 Location(involving visual axis or not)         
 Depth of involvement                                   
 Thinning (%)                                                
 Corneal sensation                                         
 Hypopyon +/-                                              
 Endothelial plaque+/-                                  
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 Satellite lesion +/-                                  
 Previous scars                                         
 Vascularization(deep/superficial)       
 
INTRAOCULAR PRESSURE (with tonopen) 
 Normal  eye Ulcer eye Difference 
Day of 
admission 
   
Day 3    
Day 6    
Day 9    
 Further IOP’ 
s 
   
    
    
    
 
 
 
 
Final IOP at healing 
 
 
 
 
 
CORNEAL SCRAPING 
1)Smear report 
2)Culture report 
3)Organism identified 
INVESTIGATION
S 
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Bacteria Fungus Culture negative/suspected 
viral ulcers   
Others 
    
 
4)Sensitivity pattern 
Sensitive Resistant Intermediate 
 
 
 5)Indication for antiglaucoma medication: 
 
6)Antiglaucoma medication started : 
 
7)Date of discharge from septic opd (at healing): 
8)Total time to healing: 
9)Outcome: 
-Healed  
-Perforated 
-Eviscerated 
-Therapeutic PKP 
-Others 
 
 Treatment done : 
 
Total no. of OPD attendance:  
 
Date of discharge: 
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   APPENDIX D 
    EXCEL DATA SHEET 
 
 
 
 
No Schell no Name Age(yrs) Sex(M=1/F=2) Previous Treatment(yes(1)/no(2) 
1 476264s Roja 24 2 1 
2 476133s Ezhumalai 30 1 1 
3 456331s Laksmi 35 2 2 
4 477008s Salman 21 1 1 
5 481122s Akbar 36 1 2 
6 486277s Thangaivel 69 1 1 
7 909002e Chitty Babu 43 1 1 
      8 492002s Nithyanandam 20 1 2 
9 485091s Amuda 50 2 2 
      10 492195s Veerapandian 50 1 02-01-1900 
      11 485686s Jeevarathnam 57 2 1 
12 317052s Varathammal 74 2 02-01-1900 
      13 485363s Saraswathy 60 2 02-01-1900 
14 477219s Lakshmi 35 2 1 
      15 473183s Ganesh 34 1 1 
27 297177s Sampangi 42 1 
                   16 473195s Parvathy 30 2 1 
      17 434903s Dayalan 61 1 2 
18 483954s Munisamy 52 1 2 
19 484155s Govindamma 38 2 1 
20 487055s Shanti C 54 2 1 
      
21 500000s 
Nageswar 
Yadav 37 1 1 
22 495419S Rajaraman 46 1 2 
23 492206s Rangasamy 85 1 02-01-1900 
24 478266s Paneerselvam 42 1 2 
25 473686s Valliammal 59 2 1 
26 480443s Muthammal 42 2 2 
27 354457s Rajammal 59 2 2 
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Systemic illness Size of infiltrate(mm) Size of epithelial defect(mm) Location 
corneal 
sensation(=/-
) 
0 2.1 * 2.1 mm 2.4* 2.1mm 2 + 
0 7.5*8mm 7.5*8mm 1 + 
0 2.5*2.5mm 2.5*2.6mm 1  + 
0 2.3*2.2 1.8*2mm 2 + 
0 1.9*1.3mm 1.8*1.3mm 1  + 
0 3mm*3mm 2.9*3mm 1 + 
0 4.5*5mm 4.5*5mm 1  + 
     0 3*3mm 3*3mm 1  + 
0 4*8mm 4*8mm 1  + 
     0 1.5*1.6mm 1.5*1.5mm 2  + 
  
3*3.5mm 
 
+ 
0 1.8*1.8mm 3.2*3mm 1 + 
0 5*7.3mm 5*7mm 1  + 
     0 3*4mm 3*4mm 1  + 
0 1.8*2mm 2*2mm 2 + 
     0 2.3*1.3mm 1.5*1.4mm 1 + 
 
2.5*2.5mm 2*2.5mm 1 + 
               0 2*2.1mm 3.4*3.5mm 1 + 
     0 7.5*5mm 7.6*5mm 1 + 
0 3*4mm 1*2mm 1 + 
1 5.8*5.8mm 5.8*5.8mm 1 + 
0 1.5*1.5mm 1*1mm 2 + 
     0 4*3mm 4*3mm 1 + 
0 3.5*3mm 3*3mm 1  + 
0 3.5*3.5mm 3*3.5mm 1  + 
0 3.0mm*2.9mm 3*3mm 2 decreased  
0 5.2*5.8mm 5.2*6.8mm 1 + 
2 5.2*4.5mm 4.5*4.8mm 2 + 
0 4*4mm 3.4*3.6mm 2 + 
Diabetes=1 
  
Central=1 
 Hypertension=2 
  
Eccentric=2 
 IHD=3 
    Asthma=4 
    Nil=0 
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Hypopyon(yes=1,no=2) Endothelial plaque(Y=1/N=2) Vascularization(y/n) 
ulcer eye(RE-1) 
(LE=2) 
2 2 N 2 
2 2 N 2 
1 2  n 2 
2 2 N 1 
2 2  n 1 
1 2 n 2 
2 2  n 2 
    2 2  n 2 
2 2  n 2 
    2 2  n 1 
    2 2 n 1 
1 2  n 1 
    1 2  n 2 
2 2 n 2 
    1 2 n 2 
                2 2 n 2 
    2 2 n 1 
2 2 n 2 
2 2 n 1 
2 2 n 1 
    1 2 n 1 
1 2  n 2 
2 2  n 1 
2 2 n 1 
1 1 n 2 
1 2 n 1 
2 1 n 1 
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Average Tonopen IOP :Day 0 ulcer 
eye(UE) Day 0 - control eye(CE) 
Day 0-Difference in 
IOP(*) 
9 10 -1 
11 12 -1 
12 12 0 
6 11 -5 
15 18 3 
7 12 -5 
5 11 -6 
   
15 11 4 
8 14 -6 
   
15 13 2 
   
11 13 -2 
5 8 -3 
   
11 10 1 
12 12 0 
   
20 17 3 
Re 
  Le 
        
19 16 3 
   
16 16 0 
7 7 0 
11 12 -1 
10 11 -1 
   
13 17 -4 
17 14 3 
15 4 11 
22 5 17 
18 9 9 
16 13 3 
15 5 10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 day 3-CE day 3* day 6-UE day6-CE day 6* 
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Day 3-UE 
12 15 -3 6 7 -1 
6 7 -1 9 8 1 
9 6 3       
10 9 1 9 6 3 
8 11 3 15 15 0 
10 11 -1 10 9 1 
11 7 4 13 15 -2 
      
16 17 -1 16 13 3 
9 13 -4 16 18 -2 
      
10 15 -5 13 12 1 
      
6 10 -4 7 14 -7 
8 9 -1 8 10 -2 
      
9 12 -3 15 12 3 
9 6 3 9 8 1 
      
18 16 2 14 15 -1 
      13,14 
                 
18 14 4 18 15 3 
      
16 16 0 15 15 0 
12 11 1 11 10 1 
14 13 1 9 11 -2 
9 8 1 11 10 1 
      
13 15 -2 18 19 -1 
15 15 0 15 15 0 
13 4 9 19 4 15 
7 6 1 7 7 0 
17 9 8 17 9 8 
18 13 5 29 14 15 
8 4 4 12 10 2 
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day9-UE day9-CE day 9* day 12-UE day12-CE day 12* 
6 13 -7 7 6 1 
8 10 -2 11 7 4 
            
13 11 2       
20 16 4 17 16 1 
10 9 1 8 9 -1 
12 13 -1 10 13 -3 
      
15 12 3 16 17 -1 
12 16 -4 16 15 1 
      
11 10 1 11 13 -2 
      
10 11 -1       
7 9 -2 12 8 4 
      
12 16 -4 11 15 -4 
9 10 -1       
      
15 15 0 15 16 -1 
                        
14 12 2 14 13 1 
      
11 12 -1 15 13 2 
13 12 1       
10 11 -1       
            
      
            
19 15 4 21 14 7 
18 4 16 16 4 12 
6 7 1 7 7 0 
16 18 -2 16 16 0 
18 17 1 12 15 -3 
12 11 1       
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day15-
UE day15-CE 
day 
15* day 18-UE day18-CE 
day 
18* day 21-UE day 21-CE day 21 * 
7 8 -1             
9 10 -1 12 14 -2       
                  
                  
15 15 0             
12 10 2             
                  
         12 13 -1 12 15 -3       
18 14 4             
                           
                           
10 12 -2 7 10 -3 13 15 ---2 
                           
                  
         14 15 -1             
                           14 16 -2             
         14 16 -2 15 16 -1 15 16 -1 
                  
                  
                  
                           
16 9 7 18 19 -1 13 17 -4 
                  
                  
                  
                  
                  
         
         
        
1 
        
2 
        
3 
        
4 
        
5 
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Culture 
Size of 
infiltrate(mm) Infiltrate size-code no: 
Time to 
heal(days) Outcome 
2 Curvularia 2.1 2 25 1 
3 No growth 8 3 27 1 
3 No growth 2.5 2 5 1 
4 Nocardia 2.3 2 10 1 
3 No growth 1.9 1 27 1 
2 Septate fungi 3 2 25 1 
3 No growth 5 3 23 1 
      1 Atypical mycobacteria 3 2 30 5 
1 E coli 8 3 20 1 
      2 Fusarium 1.6 1 16 1 
      2 Fusarium 1.8 1 14 1 
3 No growth 7.3 3 35 1 
      4 Nocardia 4 2 15 1 
3 No growth 2 2 15 1 
      2 Fusarium 2.3 2 24 1 
 
No growth 
   
Scarred with vascularization and thinning 
              2 Fusarium 2.1 2 24 1 
      5 Acanthamoeba 7.5 3 26 1 
1 Gram+ cocci 4 2 19 1 
2 Aspergillus 5.8 3 23 1 
1 Beta hemolytic streptococcus 1.5 1 10 1 
      2 Aspergillus 4 2 20 1 
2 Fusarium 3.5 2 37 1 
1 Streptococcus pneumoniae 3.5 2 12 1 
2 Fusarium 3 2 25 1 
1 Pseudomonas aeruginosa 5.8 3 24 1 
1 Streptococcus pneumoniae 5.2 3 23 1 
3 No growth 4 2 21 1 
     
Outcome: 
     
Healed with scar=1 
Bacterial 
  
<2mm=  1 
 
perforated=2 
Fungal 
  
 2-4mm=2 
 
Eviscerated=3 
No Growth 
  
 >4mm=  3 
 
Therapeutic PKP=4 
Nocardia 
    
Patient did not come for further follow up=5 
Acanthamoeba 
    
Vascularization with scarring=6 
     
Pthysical=7 
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Time to 
heal(days) Outcome 
25 1 
27 1 
5 1 
10 1 
27 1 
25 1 
23 1 
  30 5 
20 1 
  16 1 
  14 1 
35 1 
  15 1 
15 1 
  24 1 
 
Scarred with vascularization and thinning 
    24 1 
  26 1 
19 1 
23 1 
10 1 
  20 1 
37 1 
12 1 
25 1 
24 1 
23 1 
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21 1 
 
Outcome: 
 
Healed with scar=1 
 
perforated=2 
 
Eviscerated=3 
 
Therapeutic PKP=4 
 
Patient did not come for further follow up=5 
 
Vascularization with scarring=6 
 
Pthysical=7 
   
 
